THDB(SH:600867) Shang Hai Zheng Quan Bao·2025-12-15 20:53Group 1 - The fourth extraordinary general meeting of shareholders for Tonghua Dongbao Pharmaceutical Co., Ltd. was held on December 15, 2025, with no resolutions being rejected [2] - The meeting was convened by the board of directors and chaired by Chairman Li Jiahong, utilizing a combination of on-site and online voting methods [2][3] - All nine current directors attended the meeting, including independent directors, and the company’s senior management was also present [3] Group 2 - Several proposals were reviewed and approved, including the draft of the employee stock ownership plan for the R&D and production system, the management measures for the employee stock ownership plan, and the authorization for the board to handle related matters [4] - A proposal to provide financial assistance to a controlling subsidiary was also approved [5] - The meeting's proceedings and voting were confirmed to comply with relevant laws and regulations, with no related shareholders needing to abstain from voting [5]